Kuen-feng Chen
No. 7, Chung Shan South Road, 100
TPQ, Taiwan
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1.
Journal: Cancer letters
Published: February 28, 2020
Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 09, 2018
Corrigendum to "Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation" [Lung Cancer 112 (October) (2017) 81-89].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 08, 2018
Corrigendum to "Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation" [Lung Cancer 112, (October) (2017) 81-89].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 24, 2018
Antagonizing SET Augments the Effects of Radiation Therapy in Hepatocellular Carcinoma through Reactivation of PP2A-Mediated Akt Downregulation.
Journal: The Journal of pharmacology and experimental therapeutics
Published: March 13, 2018
Corrigendum to "Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity" [Eur. J. Med. Chem. 55 (2012) 220-227].
Journal: European journal of medicinal chemistry
Published: November 09, 2017
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 03, 2017
Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer.
Journal: Expert opinion on therapeutic targets
Published: May 27, 2017
Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.
Journal: International journal of molecular sciences
Published: May 02, 2017
Corrigendum: Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma.
Journal: Scientific reports
Published: April 11, 2017
Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".
Journal: Journal of hepatology
Published: March 18, 2017
Last Updated: 09/26/2026